Factor VII antibody
Quick Overview for Factor VII antibody (ABIN7673037)
Target
See all Factor VII (F7) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- F7 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- coagulation factor VII(serum prothrombin conversion accelerator)
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
Alternative Name
- F7
-
Background
-
Synonyms: Coagulation factor VII|Proconvertin|Serum prothrombin conversion accelerator (SPCA)|Factor VII light chain|Factor VII heavy chain|F7
Background: Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
-
Molecular Weight
- 49-55 kDa
-
Gene ID
- 2155
-
UniProt
- P08709
-
Pathways
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Target
-